Nicholas Glanville
Vice President Research Prokarium
Nicholas Glanville is the Vice President Research at Prokarium, a London-based biotech developing novel microbial cancer immunotherapies. Nick’s experience encompasses basic science through phase II clinical studies across academic, contract research and biotech organisations and a range of therapeutic modalities. He gained a PhD in Immunology from Imperial College London where he spent many years as a researcher before moving to industry.
Seminars
Wednesday 3rd December 2025
Fireside Chat: Examining the Future of Tumour Modelling
5:00 pm
- Hybrid submissions – will they become the new standard or the new normal?
- Balancing in vivo versus in vitro and 3D in model selection
- Debunking the role of in vivo models and non-animal tests to inform future clinical trial design
